Johnson & Johnson CEO Alex Gorsky on awaiting the FDA’s authorization of his company’s single-dose COVID-19 vaccine, efforts to update the vaccine in response to new variants, and ramping up production to deliver 100 million doses to the U.S. when the time comes.
